mochi tirzepatide doses compounded semaglutide Tirzepatide: Dosage, Pricing & More Over the past 7.5 months Mochi Health GLP-1 Review: Wide – PSA 🗣️🗣️🗣️🗣️🗣️ Mochi just put

After tirzepatide was approved for marketing in the United States in 2022, the number of prescriptions has continued to grow rapidly, and the growth rate far exceeds that of semaglutide during the same period, driving the rapid increase of tirzepatide's market share

Even as Wegovy, Mounjaro, and other GLP-1 therapies become household names on par with Tylenol and Kleenex, financially burdened payers and employers are beginning to restrict coverage and drop the drugs from their formularies

Insurance coverage for GLP-1 medications like Ozempic has become increasingly restrictive, with most major carriers including Aetna limiting approval to patients with diagnosed type 2 diabetes rather than obesity alone

Visible changes: noticeable to people around you, clothing sizes may change